What Opis S.r.l. does

Opis S.r.l. is a privately held international clinical contract research organization (CRO) founded in 1998. According to its firmographic profile, the company provides clinical research services supporting drug and medical device studies, indicating it operates in the regulated life-sciences outsourcing market serving pharmaceutical, biotechnology, and medical device sponsors that require third-party execution of clinical trials.

The firm's website (opiseurope.com) suggests a European operating footprint, consistent with its Italian corporate form (S.r.l. = Società a responsabilità limitata). However, the source webpage returned only a loading/verification screen during data collection, so no substantive detail on platform architecture, proprietary technology, therapeutic-area specialization, geographic service coverage, or operational scale is available. No technology stack, proprietary features, certifications, or product-specific descriptions were disclosed.

No revenue model, pricing structure, customer list, management team, partnership portfolio, funding history, or M&A activity is documented in the input. Consequently, the business model — typical CRO economics of fee-for-service study execution, project-based contracts, and sponsor billable rates — cannot be confirmed from primary sources. Any deeper conclusions on unit economics, deal velocity, or competitive positioning would require additional disclosure not present in the supplied data.

Name

Opis S.r.l.

Website

https://opiseurope.com

Company type

Private

Founded year

1998

Operating status

Operating

Short description

Opis S.r.l. is a privately held international clinical contract research organization founded in 1998, providing clinical research services for drug and medical device studies to pharmaceutical, biotech, and medical device sponsors.

Ownership category

akta.pro rank

Product category

Clinical Research Services (Contract Research Organization)

NAICS

Scientific Research and Development Services (5417)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Clinical research services
• Contract research organization
• Drug clinical trials
• Medical device studies
• Clinical trial management

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Core offering

Opis S.r.l. is an international clinical contract research organization (CRO) that provides clinical research services for drug and medical device studies. The company supports clinical trial execution and related research activities on behalf of pharmaceutical and medical device sponsors, operating as an outsourced partner for clinical development programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Services for Drug Studies
• Clinical Research Services for Medical Device Studies

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• ICON plc: Global clinical CRO offering full-service Phase I–IV drug and device trial execution. Highly comparable to Opis in core service offering (clinical research services for drug and device studies), though materially larger and with broader global reach.
• Parexel International: Mid-to-large global clinical CRO focused on drug and device studies across multiple therapeutic areas. Directly comparable service portfolio to Opis, with stronger therapeutic specialization and global footprint.
• Clinipace Worldwide (now dMed): Mid-market clinical CRO providing drug and device clinical research services. Comparable service portfolio and target market to Opis, particularly in the small-to-mid biotech sponsor segment.
• CTI Clinical Trial & Consulting Services: Mid-sized privately held clinical CRO offering drug and device trial services across multiple therapeutic areas. Comparable in mid-market positioning and full-service clinical CRO focus.
• Medpace Holdings: Mid-sized full-service clinical CRO with strong presence in Phase II–IV drug and device trials. Comparable in clinical CRO focus and mid-market positioning, though Medpace is significantly larger and US-listed.
• Worldwide Clinical Trials: Mid-sized global clinical CRO providing Phase I–IV drug and device study services. Closely comparable in scale, service mix, and sponsor profile to a smaller European clinical CRO like Opis.
• Advanced Clinical: US-headquartered mid-sized clinical CRO providing drug and device trial services, including functional service offerings. Comparable in service scope and mid-market positioning to a smaller European CRO.
• PSI CRO: Privately held mid-sized European-headquartered global clinical CRO providing drug and device trial services. Closely comparable in European base, mid-market positioning, and full-service clinical CRO focus.

Broad incumbents

• Charles River Laboratories: Major CRO with both preclinical and clinical services for drug development. Overlaps with Opis on the clinical side while also serving discovery/preclinical work, making it a broader but comparable peer.
• IQVIA: Largest global CRO and life sciences technology provider, offering full-service clinical research plus data, analytics, and technology platforms. Comparable in core clinical CRO offering but vastly larger and broader in scope.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat1 record

Key risks4 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Opis S.r.l.